We examined the full universe of profitable Nordic-listed pharmaceutical firms to identify which companies are structurally resilient in the face of U.S.
In the above "Benchmarking" tyble the Astra Zeneca Description text was copied in twice and thereby overwrites the Novo Nordisk description?
Hi! Good spot; only the name was duplicated and has now been fixed. Thanks.
In the above "Benchmarking" tyble the Astra Zeneca Description text was copied in twice and thereby overwrites the Novo Nordisk description?
Hi! Good spot; only the name was duplicated and has now been fixed. Thanks.